跳至主要内容
临床试验/NCT05821075
NCT05821075招募中1 期

Comparative Study Between Prednisolone, Cerebrolysin in the Treatment of Bell's Palsy

October 6 University1 个研究点 分布在 1 个国家目标入组 90 人开始时间: 2023年8月24日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
1 期
状态
招募中
入组人数
90
试验地点
1
主要终点
changes in scores of the Sunnybrook grading system.

研究概览

简要总结

Bell's palsy, a peripheral facial nerve paresis, is the most common disorder of the facial nerve and one of the most common mononeuropathies.

Many patients with Bell's palsy will develop some complications such as synkinesis, crocodile tears and 'sweating' of the ear while eating Commonly used medications to treat Bell's palsy is Corticosteroids Cerebrolysin stimulates the regeneration of the nervous tissue with protective action we aim to study the efficacy of cerebrolycin in Bell's palsy

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 60 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • unilateral acute facial palsy of no identifiable cause

排除标准

  • Recurrent facial Bell's palsy
  • Pregnancy
  • Severe hypertension,
  • Renal or hepatic disease,
  • Gastric or duodenal ulcer
  • presence of acute otitis media or ipsilateral chronic otitis
  • Recent head injury,
  • psychiatric disease
  • If there is any contraindications for corticosteroids

研究组 & 干预措施

Prednisolone

Active Comparator

干预措施: Prednisolone (Drug)

Cerebrolysin

Active Comparator

干预措施: Cerebrolysin (Drug)

Prednisolone and Cerebrolysin

Active Comparator

干预措施: Prednisolone (Drug)

Prednisolone and Cerebrolysin

Active Comparator

干预措施: Cerebrolysin (Drug)

结局指标

主要结局

changes in scores of the Sunnybrook grading system.

时间窗: at baseline, after 1 week, after 3 week

change in scores of the house Brackman grading system HB

时间窗: at baseline, after 1 week, after 3 week

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

engy wahsh

LECTURER OF CLINICAL PHARMACY

October 6 University

研究点 (1)

Loading locations...

相似试验